Abstract
Many systemic complications follow aneurysmal subarachnoid hemorrhage and are primarily due to sympathetic nervous system activation. These complications play an important role in the overall outcome of patients. The purpose of this review is to provide an update on the diagnosis, pathophysiology, and management of systemic complications specifically associated with aneurysmal subarachnoid hemorrhage. Special focus has been made on systemic complications that occur more frequently in patients with aneurysmal subarachnoid hemorrhage compared to other stroke subtypes and in the neurocritical care patient population. These complications include neurogenic pulmonary edema, electrocardiographic changes, troponin elevation, neurogenic stunned myocardium, hyponatremia, and anemia.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Diringer MN, Bleck T, Hemphill C, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40. Print. Diringer et al. as part of the Neurocritical Care Society’s Multidisciplinary Consensus Conference reviewed the literature and provided evidence-based guidelines for the critical care management of patients following aneurysmal subarachnoid hemorrhage.
Chen S, Qian Li WH, Krafft PR, et al. The harmful effects of subarachnoid hemorrhage on extracerebral organs. Biomed Res Int. 2014;2014:1–12. Print.
Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8(3):404–12. Print.
Davison DL, Chawla LS, Selassie L, et al. Neurogenic pulmonary edema. Chest. 2012;141(3):793–5. Print.
Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):188–92. Print.
Friedman JA, Pichelmann MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52(5):1025–32. Print.
Davison DL, Terek M, Chawla LS. Neurogenic pulmonary edema. Crit Care. 2012;16(2):212. Print.
Fontes RB, Aguiar PH, Zanetti MV, et al. Acute neurogenic pulmonary edema: case reports and literature review. J Neurosurg Anesthesiol. 2003;15(2):144–50. Print.
Sakr YL, Ghosn I, Vincent JL. Cardiac manifestations after subarachnoid hemorrhage: a systematic review of the literature. Prog Cardiovasc Dis. 2002;45(1):67–80. Print.
Goldfinger JZ, Nair A, Sealove BA. Brain-heart interaction in takotsubo cardiomyopathy. Heart Fail Clin. 2013;9(2):217–23. Print.
Lee VH, Oh JH, Mulvagh SL, Wijdicks E. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243–9. Print.
Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36(4):1328–35. Print.
Chatterjee S. ECG changes in subarachnoid haemorrhage: a synopsis. Neth Hear J. 2010;19(1):31–4. Print.
Tung P. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35(2):548–51. Print.
Naidech AM. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851–6. Print.
Abd TT, Hayek S, Cheng J, et al. Incidence and clinical characteristics of takotsubo cardiomyopathy post-aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2014;176(3):1362–4. Print.
• Bulsara KR, Mcgirt MJ, Liao L, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(3):524–8. Print. Bulsara et al. retrospectively reviewed 350 patients with aneurysmal subarachnoid hemorrhage and proposed new criteria to differentiate neurogenic stunned myocardium from acute myocardial infarction.
Kurisu S, Kihara Y. Tako-tsubo cardiomyopathy: clinical presentation and underlying mechanism. J Cardiol. 2012;60(6):429–37. Print.
Ancona F, Bertoldi LF, Ruggieri F, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different: table 1. Eur Heart J. 2016. Print.
Yee AH, Burns JD, Wijdicks E. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21(2):339–52. Print.
Mcgirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004;54(6):1369–74. Print.
Mapa B, Taylor BE, Appelboom G, et al. Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg. 2016;85:305–14. Print.
Marik PE. Techniques for assessment of intravascular volume in critically ill patients. J Intensive Care Med. 2009;24(5):329–37. Print.
Moretti R, Pizzi B. Inferior vena cava distensibility as a predictor of fluid responsiveness in patients with subarachnoid hemorrhage. Neurocrit Care. 2010;13(1):3–9. Print.
Filippatos TD, Liamis G, Christopoulou F, Elisaf MS. Ten common pitfalls in the evaluation of patients with hyponatremia. Eur J Intern Med. 2016;29:22–5. Print.
Maesaka JK, Miyawaki N, Palaia T, et al. Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int. 2007;71(8):822–6. Print.
Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14(4):182–7. Print.
• Maesaka JK, Imbriano L, Mattana J, et al. Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia. J Clin Med. 2014;3(4):1373–85. Print. Maesaka et al. reviewed the differences between cerebral salt wasting and SIADH, highlighted the pitfalls of previous diagnostic approaches, and proposed a new volume independent algorithm for the evaluation of hyponatremia.
Pierrakos C, Taccone F, Decaux G, et al. Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience. Ann Intensive Care. 2012;2(1):13. Print.
Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol. 2008;19(2):194–6. Print.
Naidech AM, Jovanovic B, Wartenberg KE, Parra A, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage*. Crit Care Med. 2007;35(10):2383–9. Print.
• Roux PDL. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):342–53. Print. Roux et al. reviewed 27 articles about the effects of red blood cell transfusion in patients with aneurysmal subarachnoid hemorrhage. Most of the articles were very low quality according to the GRADE criteria. The authors concluded that it is not clear if red blood cell transfusion is a marker of disease severity or independent risk factor for worse outcome.
Stein M, Brokmeier L, Herrmann J, Scharbrodt W, et al. Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction. J Clin Neurosci. 2015;22(3):530–4. Print.
Dhar R, Zazulia AR, Videen TO, et al. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009;40(9):3039–44. Print.
Smith MJ, Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101(1):1–7. Print.
Kurtz P, Helbok R, Claassen JJ, et al. The effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Neurocrit Care. 2015;24(1):118–21. Print.
Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013;79(2):307–12. Print.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ravi Garg and Barak Bar declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Neurology of Systemic Diseases
Rights and permissions
About this article
Cite this article
Garg, R., Bar, B. Systemic Complications Following Aneurysmal Subarachnoid Hemorrhage. Curr Neurol Neurosci Rep 17, 7 (2017). https://doi.org/10.1007/s11910-017-0716-3
Published:
DOI: https://doi.org/10.1007/s11910-017-0716-3